Last reviewed · How we verify
NCT05082194
Balance Eyesight and Muscle Tension in the Cervical Spine in Cerebral Amyloid Angiopathy
trial testing balance with open and closed eyes in Cerebral Amyloid Angiopathy in 16 participants. Completed in 10 October 2020.
15 June 2020
Quick facts
| Lead sponsor | Anna Olczak |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 16 |
| Start date | 10 February 2020 |
| Primary completion | 15 June 2020 |
| Estimated completion | 10 October 2020 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- balance with open and closed eyes
Conditions studied
- Cerebral Amyloid Angiopathy — all drugs for Cerebral Amyloid Angiopathy →
Sponsor
Anna Olczak
Who can join
Adults 55 to 90, any sex, with Cerebral Amyloid Angiopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cerebral Amyloid Angiopathy (CAA) is one form of disease of the small vessels of the brain and can cause frequent cerebral hemorrhages as well as other types of stroke. The aim of the research was to examine the balance of the body in patients after a stroke and to determine how the tension of selected muscles of the cervical spine changes under the conditions of statics and dynamics, depending on the visual control or its absence.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05082194
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebral Amyloid Angiopathy
Currently open trials in the same condition.
- NCT06933212 — Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy. · recruiting
- NCT06393712 — A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy · Phase 2 · recruiting
- NCT05734378 — Prognosis of Cerebral Small Vessel Disease · recruiting
- NCT04204642 — SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA) · recruiting
- NCT06128824 — High Frequency Imaging in Cerebral Amyloid Angiopathy · active not recruiting
Other Anna Olczak trials
Trials by the same sponsor.
- NCT06748378 — Gait Parameters After Using the Tilt-table Exercise and Motor Imagery. · NA · completed
- NCT06276075 — The Impact of Erigo®Pro Therapy and Motor Imagery on the Balance of Stroke Patients. · NA · completed
- NCT04886466 — Importance of Core Stability for Coordinated Movement of the Human Body in Stroke Rehabilitation · NA · completed
- NCT04771533 — Passive Stabilization of the Trunk and Upper Arm in Hand Rehabilitation After Stroke · NA · completed
- NCT04889612 — Motor Coordination and Grip Strength of the Dominant and Non-dominant Hand and Wrist in Post-stroke Patients. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05082194 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Anna Olczak
- Last refreshed: 18 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05082194.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing